Between disputed claims, unconstitutional payments and the new global push for higher prices, the PBS rebate system sits on increasingly shaky ground. It has delivered access and spending control, and might be more important than ever, given global shifts by US frustration, but it has the appearance of a complete mess. …
What next for PBS rebate system amid constitutional breaches, disputed claims, and global pressure?
November 6, 2025 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
The industry walked out on Britain, and what it cost to win them back
October 22, 2026 - - Latest News -
BioNTech opens mRNA plant, putting Melbourne's north on the biotech map
October 22, 2026 - - Latest News -
An architect of the first industry–Commonwealth medicines pact to lead CSL
October 21, 2026 - - Latest News -
Quarterly update shows Telix holds course for a US$1 billion milestone year
October 21, 2026 - - Latest News -
Chemist Warehouse keeps growing as Sigma sets its sights on oral GLP-1s
October 21, 2026 - - Latest News -
America's ever rising GLP-1 curve and how Australia is following
October 21, 2026 - - Latest News -
Patient groups across Asia-Pacific push for a say on medicine prices
October 21, 2026 - - Latest News